Rapid Multifocal Neurologic Decline in an Immunocompromised Patient

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Presents a case of an elderly male patient diagnosed with chronic lymphocytic leukemia (CLL).
• Patient was undergoing treatment with a combination of prednisone, fludarabine, cyclophosphamide, and rituximab.
• Highlights the complexity of managing neurological complications in immunocompromised patients.

Observation:

• The patient exhibited progressive multifocal neurological decline.
• Despite extensive clinical and laboratory investigations, the cause remained elusive.
• A trial of methylprednisolone therapy did not alter the clinical course.

Findings:

• The patient's neurological decline was ultimately fatal, leading to death within two months.
• Neuropathologic examination was crucial for determining the final diagnosis.
• The study discusses the approach to diagnosing neurological conditions in immunosuppressed individuals.

Implications:

• Emphasizes the importance of thorough neuropathologic examination in diagnosing neurological decline in immunosuppressed patients.
• Underscores the challenges in identifying and treating neurological complications in patients with hematologic malignancies.
• Provides insights into the management strategies for progressive neurological deterioration in immunocompromised individuals.